Changeflow GovPing Healthcare & Life Sciences FDA Variance Application from William Moore - P...
Routine Consultation Added Consultation

FDA Variance Application from William Moore - Public Comment

Email

Summary

The FDA is accepting public comments on a variance application submitted by William Moore. The comment period is open until March 13. This action pertains to a specific application for a variance.

Published by FDA on regulations.gov . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

The Food and Drug Administration (FDA) is seeking public comment on a variance application submitted by William Moore. The application details are available for review, with a redacted version provided for public access. The FDA's Center for Devices and Radiological Health (CDRH) is listed as an author.

Interested parties are invited to submit comments on this variance application. The deadline for submitting comments is March 13. While the specific nature of the variance is not detailed in the provided text, regulated entities, particularly those in the drug and medical device sectors, should review the application and consider submitting comments if relevant to their operations.

What to do next

  1. Review the variance application from William Moore.
  2. Submit comments to the FDA by March 13 if relevant.

Archived snapshot

Mar 16, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Content

There are no documents available to view or download

Attachments 2

Variance Application from William Moore

Restricted: Personally Identifiable Information

More Information
- Author(s) CDRH

Variance Application from William Moore_Redacted

More Information
- Author(s) CDRH
Download

Get daily alerts for Regs.gov: Food and Drug Administration

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from FDA.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
FDA
Compliance deadline
March 13th, 2026 (39 days ago)
Instrument
Consultation
Legal weight
Non-binding
Stage
Consultation
Change scope
Minor

Who this affects

Applies to
Drug manufacturers Medical device makers Pharmaceutical companies
Geographic scope
National (US) National (US)

Taxonomy

Primary area
Healthcare
Operational domain
Compliance
Topics
Medical Devices Pharmaceuticals

Get alerts for this source

We'll email you when Regs.gov: Food and Drug Administration publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!